Media & Analysis
3 Q&A interviews with MVA-membersContact person
3 Q&A interview with Kristina Thored, Vice President CDMO, MVA member Galenica
1) What are the key advantages to being in the Swedish-Danish Medicon Valley region? Galenica was founded in Malmö in 1999, at a time when the area was dominated by larger pharmaceutical companies but lacked the presence of a more agile and specialized CDMO. With the growth of the Medicon Valley...
3 Q&A interview with Karri Nieminen, Business Development Director, Europe, new MVA member SanaClis
1) How do you think SanaClis can contribute to the Medicon Valley life science ecosystem? SanaClis can significantly contribute to the Medicon Valley life science ecosystem by leveraging our capabilities as a full-service Global CRO. We are also one of the few service providers with an extensive...
3 Q&A interview with Emma Guilhou, Business Development Manager at MVA member, GTP Bioways
1) What are the unique features of GTP Bioways? GTP Bioways, a French CDMO with more than 20 years’ experience, provides one-stop-shop services to biopharma companies. From late-stage discovery through preclinical and clinical trials to market readiness, we provide seamless support across the...
3 Q&A interview with Client Director, Stuart Schofield, new MVA member Mannaz
Q1) With regards to leadership, what are some of the pressing industry specific challenges for the life science industry? Global healthcare expenditure is growing, leading to surging R&D investments, with new modalities and digital acceleration taking pace. For leaders in the pharmaceutical...
3 Q&A interview with Jonathan Stone, Head of Northern Europe, MVA member Benchling
1) Why has Benchling decided to join MVA and focus on the Nordics and the Medicon Valley region? For the past 3 years, we’ve been hosting a Nordic Digital Science & Innovation Day in Copenhagen. It’s one of those opportunities that everyone in our company truly anticipates, and that’s because...
3 Q&A Interview with Kamilla Have, general manager, MVA member Jazz Pharmaceuticals
1) What is Jazz Pharmaceuticals Nordics focusing on in the Medicon Valley region and the Nordics? We focus on bringing innovative treatments to people living with serious and rare neurological and oncological diseases, and their families. And we focus on doing it in partnership with others. We are...
3 Q&A interview with Vice President Martin Jakobsson from new MVA member company, TÜV SÜD Denmark
1) Why have you chosen Copenhagen and the Medicon Valley region as the location of your new office? The ease of doing business: In fact, the World Bank testifies Denmark a ranking as No. 4 here. Denmark also tops the list of the world’s least corrupt countries once more on the 2023 Corruption...
3 Q&A Interview with Torben Thers Nørgaard General Manager, Cencora Pharmalex Nordic
Q1) What do you think are the most unique characteristics of the Medicon Valley life science cluster and the life science in Denmark and Sweden as such? Medicon Valley is the heart of Nordic life science. Positioned strategically between Scandinavia and the rest of Europe, Medicon Valley offers...
3 Q&A Interview with Shahin Hojjati, Regional Sales Manager Biotech Benelux & Nordics, Fisher Scientific
1) What do you consider the most relevant must-win challenge for your part of the life science industry? Our primary focus is ensuring that our customers not only view us as their preferred supplier for lab supplies but also as a strategic partner dedicated to optimizing their workflows. Beyond...
3 Q&A Interview with Anders Thelborg, General Manager at MVA-member, Bristol-Myers Squibb
1) Why has BMS as a global life science company decided to co-fund and establish a life science entrepreneurship course at KU? In 2016, Bristol Myers Squibb Denmark, the Danish Foundation for Entrepreneurship, and the University of Copenhagen (Faculty of Health and Medical Sciences) decided to...